Auteurs Bouguerra H, Amal G, Clavel S, Boussen H, Louet JF, Gati A
Endocrine connections Jun 2020
Metabolic Reprogramming of Macrophages in Atherosclerosis: Is It All about Cholesterol?Auteurs Yvan-Charvet L, Ivanov S
Journal of lipid and atherosclerosis May 2020
BAX inhibitor-1: between stress and survival.Auteurs Lebeaupin C, Blanc M, Vallée D, Keller H, Bailly-Maitre B
The FEBS journal Mai 2020
Sulfonylguanidine Derivatives as Potential Antimelanoma Agents.Auteurs Baladi T, Hamouda-Tekaya N, Gonçalves LCP, Rocchi S, Ronco C, Benhida R
ChemMedChem Mai 2020
Bad Neighborhood: Fibrotic Stroma as a New Player in Melanoma Resistance to Targeted Therapies.Auteurs Diazzi S, Tartare-Deckert S, Deckert M
Cancers May 2020
Hepatic FNDC5 is a potential local protective factor against Non-Alcoholic Fatty Liver.Auteurs Canivet CM, Bonnafous S, Rousseau D, Leclere PS, Lacas-Gervais S, Patouraux S, Sans A, Luci C, Bailly-Maitre B, Iannelli A, Tran A, Anty R, Gual P
Biochimica et biophysica acta. Molecular basis of disease Mai 2020
Clonal selection in therapy-related myelodysplastic syndromes and acute myeloid leukemia under azacitidine treatment.Auteurs Calleja A, Yun S, Moreilhon C, Karsenti JM, Gastaud L, Mannone L, Komrokji R, Al Ali N, Dadone-Montaudie B, Robert G, Auberger P, Raynaud S, Sallman DA, Cluzeau T
European journal of haematology May 2020
A Feed-Forward Mechanosignaling Loop Confers Resistance to Therapies Targeting the MAPK Pathway in BRAF-Mutant Melanoma.Auteurs Girard CA, Lecacheur M, Ben Jouira R, Berestjuk I, Diazzi S, Prod'homme V, Mallavialle A, Larbret F, Gesson M, Schaub S, Pisano S, Audebert S, Mari B, Gaggioli C, Leucci E, Marine JC, Deckert M, Tartare-Deckert S
Cancer research Mai 2020
Starvation and antimetabolic therapy promote cytokine release and recruitment of immune cells.Auteurs Püschel F, Favaro F, Redondo-Pedraza J, Lucendo E, Iurlaro R, Marchetti S, Majem B, Eldering E, Nadal E, Ricci JE, Chevet E, Muñoz-Pinedo C
Proceedings of the National Academy of Sciences of the United States of America Mai 2020
Development of a Model for Chemical Screening Based on Collateral Sensitivity to Target BTK C481S Mutant.Auteurs Libre C, Moro-Sibilot L, Giraud S, Martin L, Verhoeyen E, Costa C, Chebel A, Bissay N, Salles G, Genestier L, Sujobert P
Cancers Apr 2020